Cochlear Limited announced the appointment of Michael Daniell to the Cochlear Board. Daniell's appointment will become effective on 1 January 2020. Daniell has worked in the medical device industry for 40 years and has extensive executive leadership experience. He was Managing Director and CEO of Fisher & Paykel Healthcare Corporation Limited from November 2001 to March 2016. Daniell was responsible for the global business and operations including the design, manufacture and marketing of innovative products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. Prior to this, Daniell held various technical management and product design roles within Fisher & Paykel Healthcare.